Navigation Links
Second-Generation Female Condom is Now Available in the United States; FC2 Female Condom Will Cost 30 Percent Less than Predecessor
Date:10/1/2009

>www.totalaccessgroup.com and Global Protection Corporation, www.globalprotection.com/store. In addition, FHC has launched a website, www.fc2femalecondom.com, which includes tiered pricing information for ordering a minimum quantity of 25,000 units directly from the Company. Price per unit declines based on the volume purchased. It is important to note that the maximum price to purchase FC2 from the Company's distributors is $0.82/unit regardless of quantity, approximately a 30% decrease from the price paid for FC1.

FHC Makes Commitment to Expanded Access and Education

Seven of the top 10 states ranked by the rate of AIDS cases are in the U.S. South. FHC is initiating a program to work with a number of southern reproductive health service organizations to provide free allotments of FC2 Female Condoms as part of an introductory awareness and education program, including training for health providers on how to integrate female condom education into reproductive health counseling.

Data from the Centers for Disease Control and Prevention (CDC) show that women represent a growing proportion of Americans living with HIV and AIDS. Over the past two decades, the percentage of women among all people living with HIV in the U.S. has increased from 8 percent to 27 percent. African American and Latino women are also disproportionately impacted by the epidemic. African American women account for 66 percent of new AIDS cases among American women, while Latino women are five times more likely than white women to be diagnosed with AIDS. The AIDS case rate is significantly higher in the U.S. South than in other regions of the country, and the prevalence of HIV and AIDS cases in some southern communities is comparable to prevalence figures for West Africa.

More than 70 reproductive health and HIV/AIDS
'/>"/>

SOURCE Female Health Company
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
2. BiPar Announces Preclinical Data Demonstrating Anti-Tumor Activity With BSI-401, Its Second-Generation PARP Inhibitor
3. Kosan Initiates Phase 2 Trial of Alvespimycin, Second-Generation Hsp90 Inhibitor, in HER2-Positive Metastatic Breast Cancer
4. TAXUS OLYMPIA Registry Shows Excellent Outcomes for High-Risk Patients Treated With Second-Generation TAXUS(R) Liberte(R) Stent
5. Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents
6. The Female Health Company Receives USAID DELIVER PROJECT Order for 5 Million Units
7. A Phase II, Randomized, Double Blind, Placebo-Controlled Dose-Escalating Study, Meets the Clinical Endpoints of MTR106 Tablets During the Treatment of Acute Migraine Attacks Without Aura in Females
8. New Data Presented on the Renessa(R) Treatment for Female Stress Urinary Incontinence
9. Female Health Company Receives Brazilian Order: Four Million FC Female Condoms
10. New Study Offers More Than a Decade of Evidence for Minimally-Invasive Surgery to Treat Female Incontinence
11. Veto of Californias Condoms in Prisons Bill: "Politics Over Public Health," Says AHF
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... Medical Corp., a majority-owned subsidiary of Speedus Corp. ... Siemens Corporate Research (NYSE: SI ) ... award-winning Zargis Cardioscan(TM) system on Amazon.com, America,s largest ... electronic stethoscope were jointly named Popular Science ... Year." Cardioscan is the world,s first FDA-cleared ...
(Date:12/14/2009)... 14 Environmental health advocates hope that ... health hazards of bisphenol A (BPA), a synthetic ... harm and other illnesses, in time for Christmas. ... , staff scientist, Natural Resources Defense Council ... for medical advice, FDA must rely on the ...
(Date:12/14/2009)... 14 Cancer patients in Finland have ... introduction of RapidArc® radiotherapy technology from Varian Medical ... only private radiotherapy clinic in the Nordic region. ... this fast and precise form of radiotherapy to ... of the abdomen and prostate. ,, RapidArc, which ...
Breaking Medicine Technology:Zargis Cardioscan 'The Intelligent Stethoscope' Now Available on Amazon.com 2Toxic Chemical bisphenol A Still Not Banned By FDA; Schumer, Gillibrand Call for Ban; Govt Official Warns Public 2Cancer Patients in Finland Gain Access to Advanced RapidArc Radiotherapy Treatments 2Cancer Patients in Finland Gain Access to Advanced RapidArc Radiotherapy Treatments 3Arcadia HealthCare Names Former Walgreens Executive Charles Goodall as Vice President of DailyMed 28TM 29 Pharmacy Operations 49722 1Arcadia HealthCare Names Former Walgreens Executive Charles Goodall as Vice President of DailyMed 28TM 29 Pharmacy Operations 49722 2Arcadia HealthCare Names Former Walgreens Executive Charles Goodall as Vice President of DailyMed 28TM 29 Pharmacy Operations 49722 3Arcadia HealthCare Names Former Walgreens Executive Charles Goodall as Vice President of DailyMed 28TM 29 Pharmacy Operations 49722 4Abbott Receives CE Mark for Companys Next Generation XIENCE PRIME 28TM 29 Drug Eluting Stent Advancing Leadership Position 49720 1Abbott Receives CE Mark for Companys Next Generation XIENCE PRIME 28TM 29 Drug Eluting Stent Advancing Leadership Position 49720 2Abbott Receives CE Mark for Companys Next Generation XIENCE PRIME 28TM 29 Drug Eluting Stent Advancing Leadership Position 49720 3ThromCat 28R 29 XT 28TM 29 Thrombectomy Catheter System Receives CE Mark 49718 1ThromCat 28R 29 XT 28TM 29 Thrombectomy Catheter System Receives CE Mark 49718 2ThromCat 28R 29 XT 28TM 29 Thrombectomy Catheter System Receives CE Mark 49718 3
... 2007 /PRNewswire-FirstCall/ --,Medivation, Inc. today announced that it ... on Monday, June 11, to discuss top-line,12-month results ... of Dimebon(TM), its lead,product candidate, in Alzheimer's disease. ... the study,will present the 12-month results for the ...
... VANCOUVER, British Columbia--(BUSINESS WIRE)--Jun 7, 2007 - ... May 23, 2007 press,release related to cryopreserved ... with the University of Helsinki,Finland, ProtoKinetix has ... determine whether AAGP(TM) treated cells could survive,after ...
Other Medicine Technology:Medivation to Host Conference Call to Discuss Top-Line 12-Month,Results From Dimebon Alzheimer's Disease Study 2Medivation to Host Conference Call to Discuss Top-Line 12-Month,Results From Dimebon Alzheimer's Disease Study 3Refrigerated Stem Cells Survive 12 Times Longer with ProtoKinetix's,AAGP 2
(Date:12/14/2009)... oxygen, drugs, and more… , ... ... in collaboration with scientists at University of Michigan, have developed ... of natural red blood cells, including softness, flexibility, and the ... primary function of natural red blood cells is to carry ...
(Date:12/14/2009)... Americold Realty Trust ("Americold") announced today that ... with the U.S. Securities and Exchange Commission (the "SEC") ... common shares. The number of shares to be offered ... yet been determined. The common shares to be sold ... Americold. ,, The joint book-running managers of the ...
(Date:12/14/2009)... 14 The National Organization for Rare Disorders ... end to lifetime and annual health insurance caps. ... a newspaper distributed widely on Capitol Hill, NORD said ... would allow caps to continue for most Americans, contrary ... health care reform and welcomes the promises made by ...
(Date:12/14/2009)... Study found simple activities like housework, gardening replaced tube ... Crouse was watching 25 or 26 hours of television ... required him to cut his tube time in half. ... considerably more calories each day, and not necessarily through ... , Much of his newly freed time was spent ...
(Date:12/14/2009)... nursing facilities (SNFs) in Ohio are making major changes ... a 92 percent increase in the state-imposed Medicaid bed ... bed per day, scheduled for December 15. The ... additional $17,520 to the state each month, or $210,240 ... ,, Nearly 96 percent of skilled nursing facilities responding ...
Breaking Medicine News(10 mins):Health News:Synthetic Red Blood Cells Developed 2Health News:Synthetic Red Blood Cells Developed 3Health News:Americold Realty Trust Files Registration Statement for Proposed Initial Public Offering 2Health News:NORD Calls for Immediate End to Lifetime Insurance Caps 2Health News:Cutting TV Time Burns More Calories 2Health News:Survey Shows Tax Increase Forcing Ohio Skilled Nursing Facilities to Make Cuts 2Health News:Survey Shows Tax Increase Forcing Ohio Skilled Nursing Facilities to Make Cuts 3
... The UCLA Department of Family Medicine, with support from the ... Research on Health and Healthcare, a group that will study ... , The network will also mentor and develop a ... disparities. , The new group to ...
... Old Victim,s Own College Summer Employment at GM Facilities in, Bloomfield and ... Levy Phillips & Konigsberg, ... ... on work clothes his father and brother wore while employed at GM,parts ...
... But vasopressin might be slightly better than norepinephrine in ... -- The artery-tightening medication vasopressin holds no overall advantage ... severe septic shock, a new study finds. , But ... cases in the study, said Dr. James. A Russell, ...
... the launch,of its first-ever online sweepstakes, the "Keep ... a chance to win a year,s supply of,Wellesse ... . The sweepstakes launched February 14, 2008 and,continues ... campaign is part of our overall strategy to ...
... (OTC Bulletin Board: CCEL) announced today that it will,hold ... 2008. The record,date for the annual meeting is May ... to elect directors will be held on March 4,2008. ... meeting., The Company also announced that the deadline ...
... and Pregnancy Program at Northwestern Memorial Provides,Multidisciplinary Care ... CHICAGO, Feb. 27 Due to advances ... (CHD), more women with,CHD are reaching adulthood and ... among these women is becoming increasingly common,thanks to ...
Other Medicine News:Health News:UCLA launches network to study health care disparities affecting minorities 2Health News:$30.3 Million Jury Verdict Believed to Be New Jersey's Largest 2Health News:Two Drugs Found Equal in Treatment of Septic Shock 2Health News:WELLESSE(TM) Announces the 'Keep Your Body in Motion' Sweepstakes 2Health News:Cryo-Cell International to Hold 2008 Annual Meeting on July 15, 2008 2Health News:Specialized Care Essential for Women With Congenital Heart Disease Undergoing Pregnancy 2Health News:Specialized Care Essential for Women With Congenital Heart Disease Undergoing Pregnancy 3
An environmentally-safe, CN-free lytic reagent designed for use on the Abbott CELL-DYN® 1800 three-part differential hematology analyzer....
... Plus is a hematology control for the ... values are provided for the five-part white ... differential on the CELL-DYN 1600 and 1700. ... stability is 75 days. Para 12 Plus ...
Indicated to facilitate the intra-luminal placement of conventional guidewires beyond stenotic lesions, including chronic total coronary occlusions....
... whole blood hematology control manufactured specifically for ... and the Coulter AcT5diff instruments. The composition ... cell differential, positioning the populations within the ... The product offers 105-day closed-vial stability and ...
Medicine Products: